Skip to main content
. 2017 Dec 19;9(10):8957–8971. doi: 10.18632/oncotarget.23420

Figure 5. GSTP1 shRNA enhanced the proliferation ability of liver cancer cells in vitro.

Figure 5

(A) CCK8 assay showed that HepG2 and Huh7 cell proliferation increased in day 5 and day 7 after GSTP1 shRNA (sh-G2) transfection. (B) GSTP1 shRNA groups (sh-G2) formed more cell colonies than sh-control groups. (C) FCM showed that GSTP1 shRNA (sh-G2) led to a decrease in G1 phase but an increase in S phase. Data were mean ± SD of three biological replicates (*P < 0.05, **P < 0.01).